Global AI Medical Imaging Software for Lung Diseases Market Analysis and Forecast 2025-2031

Summary

According to APO Research, The global AI Medical Imaging Software for Lung Diseases market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI Medical Imaging Software for Lung Diseases is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for AI Medical Imaging Software for Lung Diseases is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for AI Medical Imaging Software for Lung Diseases is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for AI Medical Imaging Software for Lung Diseases is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of AI Medical Imaging Software for Lung Diseases include Riverain Technologies, BioMind, Fosun Aitrox, Huiying Medical, United-Imaging, Deepwise, Shukun Technology, VoxelCloud and Infervision Medical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI Medical Imaging Software for Lung Diseases, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of AI Medical Imaging Software for Lung Diseases, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Medical Imaging Software for Lung Diseases, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI Medical Imaging Software for Lung Diseases revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global AI Medical Imaging Software for Lung Diseases market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for AI Medical Imaging Software for Lung Diseases revenue, projected growth trends, production technology, application and end-user industry.


AI Medical Imaging Software for Lung Diseases Segment by Company

Riverain Technologies
BioMind
Fosun Aitrox
Huiying Medical
United-Imaging
Deepwise
Shukun Technology
VoxelCloud
Infervision Medical
Siemens
Yizhun Intelligent

AI Medical Imaging Software for Lung Diseases Segment by Type

Pulmonary Nodules
Pneumonia
Other

AI Medical Imaging Software for Lung Diseases Segment by Application

Hospital
Clinic

AI Medical Imaging Software for Lung Diseases Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Medical Imaging Software for Lung Diseases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Medical Imaging Software for Lung Diseases and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Medical Imaging Software for Lung Diseases.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of AI Medical Imaging Software for Lung Diseases in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of AI Medical Imaging Software for Lung Diseases company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Medical Imaging Software for Lung Diseases revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 AI Medical Imaging Software for Lung Diseases Market by Type
1.2.1 Global AI Medical Imaging Software for Lung Diseases Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Pulmonary Nodules
1.2.3 Pneumonia
1.2.4 Other
1.3 AI Medical Imaging Software for Lung Diseases Market by Application
1.3.1 Global AI Medical Imaging Software for Lung Diseases Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 AI Medical Imaging Software for Lung Diseases Market Dynamics
2.1 AI Medical Imaging Software for Lung Diseases Industry Trends
2.2 AI Medical Imaging Software for Lung Diseases Industry Drivers
2.3 AI Medical Imaging Software for Lung Diseases Industry Opportunities and Challenges
2.4 AI Medical Imaging Software for Lung Diseases Industry Restraints
3 Global Growth Perspective
3.1 Global AI Medical Imaging Software for Lung Diseases Market Perspective (2020-2031)
3.2 Global AI Medical Imaging Software for Lung Diseases Growth Trends by Region
3.2.1 Global AI Medical Imaging Software for Lung Diseases Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global AI Medical Imaging Software for Lung Diseases Market Size by Region (2020-2025)
3.2.3 Global AI Medical Imaging Software for Lung Diseases Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global AI Medical Imaging Software for Lung Diseases Revenue by Players
4.1.1 Global AI Medical Imaging Software for Lung Diseases Revenue by Players (2020-2025)
4.1.2 Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Players (2020-2025)
4.1.3 Global AI Medical Imaging Software for Lung Diseases Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global AI Medical Imaging Software for Lung Diseases Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global AI Medical Imaging Software for Lung Diseases Key Players Headquarters & Area Served
4.4 Global AI Medical Imaging Software for Lung Diseases Players, Product Type & Application
4.5 Global AI Medical Imaging Software for Lung Diseases Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global AI Medical Imaging Software for Lung Diseases Market CR5 and HHI
4.6.3 2024 AI Medical Imaging Software for Lung Diseases Tier 1, Tier 2, and Tier 3
5 AI Medical Imaging Software for Lung Diseases Market Size by Type
5.1 Global AI Medical Imaging Software for Lung Diseases Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global AI Medical Imaging Software for Lung Diseases Revenue by Type (2020-2031)
5.3 Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Type (2020-2031)
6 AI Medical Imaging Software for Lung Diseases Market Size by Application
6.1 Global AI Medical Imaging Software for Lung Diseases Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global AI Medical Imaging Software for Lung Diseases Revenue by Application (2020-2031)
6.3 Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Riverain Technologies
7.1.1 Riverain Technologies Comapny Information
7.1.2 Riverain Technologies Business Overview
7.1.3 Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
7.1.4 Riverain Technologies AI Medical Imaging Software for Lung Diseases Product Portfolio
7.1.5 Riverain Technologies Recent Developments
7.2 BioMind
7.2.1 BioMind Comapny Information
7.2.2 BioMind Business Overview
7.2.3 BioMind AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
7.2.4 BioMind AI Medical Imaging Software for Lung Diseases Product Portfolio
7.2.5 BioMind Recent Developments
7.3 Fosun Aitrox
7.3.1 Fosun Aitrox Comapny Information
7.3.2 Fosun Aitrox Business Overview
7.3.3 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
7.3.4 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Product Portfolio
7.3.5 Fosun Aitrox Recent Developments
7.4 Huiying Medical
7.4.1 Huiying Medical Comapny Information
7.4.2 Huiying Medical Business Overview
7.4.3 Huiying Medical AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
7.4.4 Huiying Medical AI Medical Imaging Software for Lung Diseases Product Portfolio
7.4.5 Huiying Medical Recent Developments
7.5 United-Imaging
7.5.1 United-Imaging Comapny Information
7.5.2 United-Imaging Business Overview
7.5.3 United-Imaging AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
7.5.4 United-Imaging AI Medical Imaging Software for Lung Diseases Product Portfolio
7.5.5 United-Imaging Recent Developments
7.6 Deepwise
7.6.1 Deepwise Comapny Information
7.6.2 Deepwise Business Overview
7.6.3 Deepwise AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
7.6.4 Deepwise AI Medical Imaging Software for Lung Diseases Product Portfolio
7.6.5 Deepwise Recent Developments
7.7 Shukun Technology
7.7.1 Shukun Technology Comapny Information
7.7.2 Shukun Technology Business Overview
7.7.3 Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
7.7.4 Shukun Technology AI Medical Imaging Software for Lung Diseases Product Portfolio
7.7.5 Shukun Technology Recent Developments
7.8 VoxelCloud
7.8.1 VoxelCloud Comapny Information
7.8.2 VoxelCloud Business Overview
7.8.3 VoxelCloud AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
7.8.4 VoxelCloud AI Medical Imaging Software for Lung Diseases Product Portfolio
7.8.5 VoxelCloud Recent Developments
7.9 Infervision Medical
7.9.1 Infervision Medical Comapny Information
7.9.2 Infervision Medical Business Overview
7.9.3 Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
7.9.4 Infervision Medical AI Medical Imaging Software for Lung Diseases Product Portfolio
7.9.5 Infervision Medical Recent Developments
7.10 Siemens
7.10.1 Siemens Comapny Information
7.10.2 Siemens Business Overview
7.10.3 Siemens AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
7.10.4 Siemens AI Medical Imaging Software for Lung Diseases Product Portfolio
7.10.5 Siemens Recent Developments
7.11 Yizhun Intelligent
7.11.1 Yizhun Intelligent Comapny Information
7.11.2 Yizhun Intelligent Business Overview
7.11.3 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
7.11.4 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Product Portfolio
7.11.5 Yizhun Intelligent Recent Developments
8 North America
8.1 North America AI Medical Imaging Software for Lung Diseases Revenue (2020-2031)
8.2 North America AI Medical Imaging Software for Lung Diseases Revenue by Type (2020-2031)
8.2.1 North America AI Medical Imaging Software for Lung Diseases Revenue by Type (2020-2025)
8.2.2 North America AI Medical Imaging Software for Lung Diseases Revenue by Type (2026-2031)
8.3 North America AI Medical Imaging Software for Lung Diseases Revenue Share by Type (2020-2031)
8.4 North America AI Medical Imaging Software for Lung Diseases Revenue by Application (2020-2031)
8.4.1 North America AI Medical Imaging Software for Lung Diseases Revenue by Application (2020-2025)
8.4.2 North America AI Medical Imaging Software for Lung Diseases Revenue by Application (2026-2031)
8.5 North America AI Medical Imaging Software for Lung Diseases Revenue Share by Application (2020-2031)
8.6 North America AI Medical Imaging Software for Lung Diseases Revenue by Country
8.6.1 North America AI Medical Imaging Software for Lung Diseases Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America AI Medical Imaging Software for Lung Diseases Revenue by Country (2020-2025)
8.6.3 North America AI Medical Imaging Software for Lung Diseases Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe AI Medical Imaging Software for Lung Diseases Revenue (2020-2031)
9.2 Europe AI Medical Imaging Software for Lung Diseases Revenue by Type (2020-2031)
9.2.1 Europe AI Medical Imaging Software for Lung Diseases Revenue by Type (2020-2025)
9.2.2 Europe AI Medical Imaging Software for Lung Diseases Revenue by Type (2026-2031)
9.3 Europe AI Medical Imaging Software for Lung Diseases Revenue Share by Type (2020-2031)
9.4 Europe AI Medical Imaging Software for Lung Diseases Revenue by Application (2020-2031)
9.4.1 Europe AI Medical Imaging Software for Lung Diseases Revenue by Application (2020-2025)
9.4.2 Europe AI Medical Imaging Software for Lung Diseases Revenue by Application (2026-2031)
9.5 Europe AI Medical Imaging Software for Lung Diseases Revenue Share by Application (2020-2031)
9.6 Europe AI Medical Imaging Software for Lung Diseases Revenue by Country
9.6.1 Europe AI Medical Imaging Software for Lung Diseases Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe AI Medical Imaging Software for Lung Diseases Revenue by Country (2020-2025)
9.6.3 Europe AI Medical Imaging Software for Lung Diseases Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China AI Medical Imaging Software for Lung Diseases Revenue (2020-2031)
10.2 China AI Medical Imaging Software for Lung Diseases Revenue by Type (2020-2031)
10.2.1 China AI Medical Imaging Software for Lung Diseases Revenue by Type (2020-2025)
10.2.2 China AI Medical Imaging Software for Lung Diseases Revenue by Type (2026-2031)
10.3 China AI Medical Imaging Software for Lung Diseases Revenue Share by Type (2020-2031)
10.4 China AI Medical Imaging Software for Lung Diseases Revenue by Application (2020-2031)
10.4.1 China AI Medical Imaging Software for Lung Diseases Revenue by Application (2020-2025)
10.4.2 China AI Medical Imaging Software for Lung Diseases Revenue by Application (2026-2031)
10.5 China AI Medical Imaging Software for Lung Diseases Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia AI Medical Imaging Software for Lung Diseases Revenue (2020-2031)
11.2 Asia AI Medical Imaging Software for Lung Diseases Revenue by Type (2020-2031)
11.2.1 Asia AI Medical Imaging Software for Lung Diseases Revenue by Type (2020-2025)
11.2.2 Asia AI Medical Imaging Software for Lung Diseases Revenue by Type (2026-2031)
11.3 Asia AI Medical Imaging Software for Lung Diseases Revenue Share by Type (2020-2031)
11.4 Asia AI Medical Imaging Software for Lung Diseases Revenue by Application (2020-2031)
11.4.1 Asia AI Medical Imaging Software for Lung Diseases Revenue by Application (2020-2025)
11.4.2 Asia AI Medical Imaging Software for Lung Diseases Revenue by Application (2026-2031)
11.5 Asia AI Medical Imaging Software for Lung Diseases Revenue Share by Application (2020-2031)
11.6 Asia AI Medical Imaging Software for Lung Diseases Revenue by Country
11.6.1 Asia AI Medical Imaging Software for Lung Diseases Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia AI Medical Imaging Software for Lung Diseases Revenue by Country (2020-2025)
11.6.3 Asia AI Medical Imaging Software for Lung Diseases Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA AI Medical Imaging Software for Lung Diseases Revenue (2020-2031)
12.2 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Type (2020-2031)
12.2.1 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Type (2020-2025)
12.2.2 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Type (2026-2031)
12.3 SAMEA AI Medical Imaging Software for Lung Diseases Revenue Share by Type (2020-2031)
12.4 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Application (2020-2031)
12.4.1 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Application (2020-2025)
12.4.2 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Application (2026-2031)
12.5 SAMEA AI Medical Imaging Software for Lung Diseases Revenue Share by Application (2020-2031)
12.6 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Country
12.6.1 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Country (2020-2025)
12.6.3 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings